Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Jan-24 5:13 PM View:  | Zhang Yan CFO | Evofem Biosciences, Inc. (EVFM) | 12-Jan-24 | Sale | 104 | $0.04 | $4.00 | (100%) 0.1K to 0 | |
| 22-Dec-23 4:05 PM View: | Kamdar Kim P. Director | Evofem Biosciences, Inc. (EVFM) | 21-Dec-23 | Private Sale | 10 | $0.62 | $6.21 | (100%) 10 to 0 | |
| 26-Apr-23 8:50 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 31-Dec-22 | Disposition | 50,000 | -- | -- | (21%) 236.72K to 186.72K | |
| 08-May-23 10:00 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 31-Dec-22 | Disposition | 30,000 | -- | -- | (55%) 54.06K to 24.07K | |
| 31-May-22 8:55 AM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 27-May-22 | Market Purchase | 141,000 | $0.35 | $49,702.50 | 147% 95.72K to 236.72K | 5% |
| 23-Feb-22 4:06 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 18-Feb-22 | Grant | 450,000 | -- | -- | 125% 360.98K to 810.98K | |
| 23-Feb-22 4:08 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 18-Feb-22 | Grant | 300,000 | -- | -- | 139% 216.42K to 516.42K | |
| 23-Feb-22 4:04 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 18-Feb-22 | Grant | 750,000 | -- | -- | 109% 685.84K to 1.44M | |
| 04-Jan-22 4:03 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 31-Dec-21 | Disposition | 300,000 | -- | -- | (30%) 985.84K to 685.84K | |
| 04-Jan-22 4:05 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 31-Dec-21 | Disposition | 120,000 | -- | -- | (25%) 480.98K to 360.98K | |
| 04-Jan-22 10:00 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 31-Dec-21 | Disposition | 120,000 | -- | -- | (36%) 336.42K to 216.42K | |
| 20-Dec-21 4:19 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 20-Dec-21 | Market Purchase | 135,000 | $0.38 | $50,625.00 | 16% 850.84K to 985.84K | 1% |
| 20-Dec-21 4:20 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 20-Dec-21 | Market Purchase | 25,000 | $0.39 | $9,725.00 | 8% 311.42K to 336.42K | (5%) |
| 20-Dec-21 4:20 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 20-Dec-21 | Market Purchase | 40,594 | $0.37 | $15,019.80 | 9% 440.39K to 480.98K | 0% |
| 09-Jul-21 4:02 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 08-Jul-21 | Payment of Exercise | 19,998 | $0.98 | $19,498.10 | (4%) 468.83K to 448.83K | (< 1%) |
| 21-Jun-21 5:22 PM View: | Kamdar Kim P. Director | Evofem Biosciences, Inc. (EVFM) | 18-Jun-21 | Market Purchase | 10,000 | $1.16 | $11,650.00 | 108% 9.29K to 19.29K | (6%) |
| 14-Jun-21 4:13 PM View: | O'Brien Anthony Stephen Director | Evofem Biosciences, Inc. (EVFM) | 14-Jun-21 | Market Purchase | 8,140 | $1.31 | $10,663.40 | 100% 0 to 8.14K | (5%) |
| 14-Jun-21 4:14 PM View: | Rarick Lisa Dale Director | Evofem Biosciences, Inc. (EVFM) | 11-Jun-21 | Market Purchase | 5,000 | $1.20 | $5,990.00 | 95% 5.25K to 10.25K | 11% |
| 11-Jun-21 8:19 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 11-Jun-21 | Market Purchase | 18,180 | $1.14 | $20,725.20 | 4% 450.65K to 468.83K | (8%) |
| 10-Jun-21 7:29 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 10-Jun-21 | Market Purchase | 10,000 | $1.02 | $10,250.00 | 3% 301.42K to 311.42K | 2% |
| 10-Jun-21 7:30 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 10-Jun-21 | Market Purchase | 24,500 | $1.03 | $25,235.00 | 6% 415.89K to 440.39K | 2% |
| 10-Jun-21 7:30 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 10-Jun-21 | Market Purchase | 50,000 | $1.03 | $51,500.00 | 6% 800.84K to 850.84K | (3%) |
| 21-May-21 4:26 PM View: | Culwell Kelly Chief Medical Officer | Evofem Biosciences, Inc. (EVFM) | 20-May-21 | Payment of Exercise | 42,061 | $0.86 | $36,172.50 | (13%) 315.45K to 273.39K | 0% |
| 21-May-21 4:25 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 20-May-21 | Payment of Exercise | 42,280 | $0.86 | $36,360.80 | (9%) 458.17K to 415.89K | 0% |
| 21-May-21 4:26 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 20-May-21 | Payment of Exercise | 31,480 | $0.86 | $27,072.80 | (7%) 482.13K to 450.65K | 0% |
| 21-May-21 4:25 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 20-May-21 | Payment of Exercise | 105,300 | $0.86 | $90,558.00 | (12%) 906.14K to 800.84K | 0% |
| 21-May-21 4:26 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 20-May-21 | Payment of Exercise | 42,120 | $0.86 | $36,223.20 | (12%) 343.54K to 301.42K | 0% |
| 09-Mar-21 6:59 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 09-Mar-21 | Market Purchase (Planned) | 45,249 | $2.28 | $103,168.00 | 5% 860.89K to 906.14K | (3%) |
| 03-Feb-21 8:00 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 03-Feb-21 | Grant | 200,000 | -- | -- | 77% 258.17K to 458.17K | |
| 03-Feb-21 7:57 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 03-Feb-21 | Grant | 200,000 | -- | -- | 139% 143.54K to 343.54K | |
| 03-Feb-21 8:02 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 03-Feb-21 | Grant | 200,000 | -- | -- | 71% 282.13K to 482.13K | |
| 03-Feb-21 8:05 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 03-Feb-21 | Grant | 500,000 | -- | -- | 139% 360.89K to 860.89K | |
| 03-Feb-21 7:54 PM View: | Culwell Kelly Chief Medical Officer | Evofem Biosciences, Inc. (EVFM) | 03-Feb-21 | Grant | 200,000 | -- | -- | 173% 115.45K to 315.45K | |
| 18-Nov-20 5:22 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 17-Nov-20 | Market Purchase | 7,760 | $2.17 | $16,839.20 | 3% 250.41K to 258.17K | 12% |
| 18-Nov-20 5:14 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 17-Nov-20 | Market Purchase | 9,090 | $2.20 | $19,998.00 | 7% 134.45K to 143.54K | 10% |
| 11-Sep-20 5:20 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 11-Sep-20 | Market Purchase | 3,000 | $2.08 | $6,240.00 | 1% 276.33K to 279.33K | 17% |
| 11-Sep-20 5:20 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 10-Sep-20 | Market Purchase | 1,000 | $2.71 | $2,710.00 | < 1% 275.33K to 276.33K | (11%) |
| 10-Sep-20 8:04 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 08-Sep-20 | Market Sale | 122,500 | $3.26 | $399,350.00 | (25%) 483.39K to 360.89K | 26% |
| 09-Jul-20 6:17 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 08-Jul-20 | Payment of Exercise | 20,381 | $3.30 | $67,257.30 | (7%) 295.71K to 275.33K | 26% |
| 18-Jun-20 4:29 PM View: | Rarick Lisa Dale Director | Evofem Biosciences, Inc. (EVFM) | 17-Jun-20 | Market Purchase | 5,250 | $2.99 | $15,697.50 | 100% 0 to 5.25K | (19%) |
| 17-Jun-20 8:38 PM View: | Hall William Walmsley Director | Evofem Biosciences, Inc. (EVFM) | 15-Jun-20 | Market Purchase | 5,000 | $2.85 | $14,250.00 | 100% 0 to 5.0K | (15%) |
| 15-Jun-20 4:16 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 12-Jun-20 | Market Purchase | 8,500 | $3.14 | $26,690.00 | 4% 241.91K to 250.41K | (23%) |
| 16-Jun-20 4:35 PM View: | Kamdar Kim P. Director 10% Owner | Evofem Biosciences, Inc. (EVFM) | 12-Jun-20 | Market Purchase | 5,000 | $2.94 | $14,700.00 | 117% 4.29K to 9.29K | (18%) |
| 08-Jun-20 5:43 PM View: | File Justin J. Chief Financial Officer | Evofem Biosciences, Inc. (EVFM) | 05-Jun-20 | Payment of Exercise | 42,810 | $3.31 | $141,701.00 | (15%) 280.42K to 237.6K | 27% |
| 09-Jun-20 6:49 AM View: | Invesco Ltd. 10% Owner | Evofem Biosciences, Inc. (EVFM) | 05-Jun-20 | Market Purchase | 857,143 | $3.50 | $3,000,000.00 | 3% 24.74M to 25.6M | (31%) |
| 08-Jun-20 5:42 PM View: | Pelletier Saundra L Chief Executive Officer Director | Evofem Biosciences, Inc. (EVFM) | 05-Jun-20 | Payment of Exercise | 85,620 | $3.31 | $283,402.00 | (15%) 564.71K to 479.08K | 27% |
| 08-Jun-20 5:41 PM View: | Fitzpatrick Alexander A General Counsel and Secretary | Evofem Biosciences, Inc. (EVFM) | 05-Jun-20 | Payment of Exercise | 31,590 | $3.31 | $104,563.00 | (19%) 166.04K to 134.45K | 27% |
| 08-Jun-20 5:43 PM View: | Culwell Kelly Chief Medical Officer | Evofem Biosciences, Inc. (EVFM) | 05-Jun-20 | Payment of Exercise | 31,548 | $3.31 | $104,424.00 | (21%) 147.0K to 115.45K | 27% |
| 08-Jun-20 5:42 PM View: | Barrans Russell Chief Commercial Officer | Evofem Biosciences, Inc. (EVFM) | 05-Jun-20 | Payment of Exercise | 15,455 | $3.31 | $51,156.10 | (5%) 309.24K to 293.79K | 27% |
| 09-Jun-20 9:08 PM View: | Acacia Research Corp 10% Owner | Evofem Biosciences, Inc. (EVFM) | 04-Jun-20 | Market Sale | 9,138,500 | $3.21 | $29,325,500.00 | (100%) 9.14M to 1.0K | 25% |
